The effects of chronic trimipramine treatment on biogenic amine metabolism and on dopamine D2, 5-HT2 and tryptamine binding sites in rat brain
- Gen Pharmacol. 1990;21(5):759-62. doi: 10.1016/0306-3623(90)91030-u.
- 1. Neuropsychiatric Research Unit, University of Saskatchewan, Saskatoon, Canada.
1. Two week chronic administration of trimipramine increased the brain concentration and metabolism of dopamine and 5-hydroxytryptamine. 2. The treatment also produced a reduction in dopamine D2 and 5-hydroxytryptamine 5-HT2 receptors but no change in tryptamine binding was observed. 3. These findings suggest that trimipramine induces adaptive changes in dopamine and 5-hydroxytryptamine neurotransmission.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Neurological Disease
-
Research Areas: Neurological Disease
-
Research Areas: Neurological Disease
-
Research Areas: Neurological Disease
-
Research Areas: Neurological Disease